Access to Health
We are committed to addressing unmet global health needs by leveraging our core competencies, expertise and experience throughout the global health community.
Focusing on low- and middle-income countries, we implement and strengthen holistic programs that expand access to healthcare through a robust strategy, global health partnerships and shared value initiatives. Our Access to Health (A2H) programs and initiatives address local needs, and help to create long-term value for the business, our stakeholders and the environment.
By identifying gaps in public health systems, we find opportunities for sustainable business models designed to ensure that our products and solutions reach patients in an affordable way. This applies to both neglected diseases, such as schistosomiasis and malaria, and non-communicable diseases with high prevalence in these countries.
Our Commitment for Health for All
We rank 5th in the 2022 Access to Medicine (ATM) Index.
Every two years, the ATM Index benchmarks 20 of the world’s largest pharmaceutical companies according to their efforts to advance global access to medicines. Our position among the TOP FIVE shows our continuous commitment to improving equitable and sustainable access to high quality solutions for all. In the ATM Index 2022, we perform particularly strongly in Research & Development – in this area, we ranked 4th – as well as in Intellectual Property sharing and in high-quality capacity building across all fields (R&D, manufacturing, supply chain, health system strengthening) for and in low- and middle-income countries. In addition, we keep our leadership in the fight against the neglected tropical disease, schistosomiasis, as part of our Global Health strategy.
Our focusThe United Nations adopted 17 Sustainable Development Goals. Find out how we are contributing.Learn more
Access to Health CharterTo demonstrate our commitment to expanding access to healthcare we transparently publish dedicated charters.Learn more
Sustainable Supply ChainsWe strengthen access to medicines in low- and middle-income countries by enhancing health supply chains.Learn more